SCHEMBL17853604

SCHEMBL17853604

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2ccc(-c3cc(-c4ccc(-c5cccnc5)cc4)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 3/20 0.47
▸ DHODH Q02127 1/20 0.46
▸ CYP11B1 P15538 4/20 0.43
▸ CYP11B2 P19099 4/20 0.43
▸ CYP17A1 P05093 1/20 0.43
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ NTSR1 P30989 1/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40
▸ KDR P35968 1/20 0.39
▸ TEK Q02763 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ AOC3 Q16853 1/20 0.39
▸ TP53 P04637 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853555 0.95 DHODH (0.46) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853527 0.94 DHODH (0.46) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853607 0.92 DHODH (0.46) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853514 0.92 DHODH (0.46) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL30107757 0.92 DHODH (0.43) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853564 0.91 DHODH (0.50) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853546 0.91 DHODH (0.50) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853486 0.91 DHODH (0.50) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853693 0.91 DHODH (0.50) CYP19A1DHODHCYP11B1CYP11B2CYP17A1
SCHEMBL17853561 0.91 DHODH (0.50) CYP19A1DHODHCYP11B1CYP11B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, SLC39A11 CYP19A1 482/4885DHODH 3921/4885CYP11B1 2679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback